期刊文献+

尼尔雌醇对老年高血压妇女心血管疾病危险因素的影响

The Effect of Nilestriol on Cardiovascular Disease Risk Factors in Elderly Women With Hypertension
原文传递
导出
摘要 目的 观察尼尔雌醇对老年高血压妇女心血管疾病危险因素的影响。方法 选择 41例已接受降压治疗的老年高血压妇女 ,随机分为尼尔雌醇组 (A组 )与安慰剂组 (B组 ) ,分别予以尼尔雌醇 ( 2mg ,每半月 1次 )或安慰剂 ( 2片 ,每半月 1次 )治疗共 6个月 ,采用自动生化分析法、免疫浊度法或酶联免疫吸附双抗体夹心法 (ELISA法 )分别于 0、6个月末测定患者的血糖、血脂、纤维蛋白原 (Fbg)、组织纤溶酶原激活剂 (tPA)、纤溶酶原激活剂抑制物 (PAI -1)、血管性血友病因子 (vWF)、可溶性细胞间粘附分子 (sICAM-1)及E -选择素 (E -selectin)。结果 尼尔雌醇组较安慰剂组总胆固醇 (TC)、Fbg、tPA、PAI -1、vWF、sICAM -1、E -selectin均明显降低 ,差异有统计学意义 ;甘油三酯 (TG)、低密度脂蛋白 (LDL -C)降低以及高密度脂蛋白 (HDL -C)升高 ,但差异无显著性。结论 尼尔雌醇对老年高血压妇女脂质代谢、内皮功能、纤溶凝血和炎症相关蛋白的表达具有明显改善作用 ,对血压。 Objective To observe the benefits and harms of nilestriol in elderly women with hypertension.Methods Forty-one elderly women with hypertension who had received antihypertensive therapy were randomly divided into two groups. Women in group A (n=21) received oral nilestriol, wherase those in group B(n=20) received oral placebo for six months. Blood sugar(Bs), blood lipids, soluble intercellular adhesion molecule 1(sICAM-1),E-selectin and plasma fibrinogen(Fbg),tissue-type plasminogen activator antigen(tPA),plasminogen activator inhibitor 1(PAI-1),von Willebrand factor(vWF) were measured before starting treatment and 6th month after treatment.Results Levels of total cholesterol(TC),Fbg,tPA,PAI-1,vWF,sICAM-1,E-selectin in group A were significantly lower than those in group B.Conclusions In elderly women with hypertension, nilestriol could improve the metabolism of lipids,endotheliocytes function,inflammation factors expression,thrombosis and hemostasis.
出处 《中国医师杂志》 CAS 2003年第12期1623-1625,共3页 Journal of Chinese Physician
关键词 尼尔雌醇 高血压 老年妇女 心血管疾病 危险因素 降压治疗 脂质代谢 内皮功能 Nilestriol Elderly women, Hypertension Cardiovascular disease Risk factors
  • 相关文献

参考文献7

  • 1HulleyS,GradyD,BushT.FortheHeartandEstrogen/ProgestinReplace mentStudy (HERS)ResearchGroup.Randomizedtrialofestrogenpluspro gestinforsecondaryproventionofcoronaryheartdiseaseinpostmenopausalwomen[].The Journal of The American Medical Association.1998
  • 2Barret-Connor E,Grady D.Hormone repacement therapy, heart disease, and other considerations[].Annual Review of Public Health.1998
  • 3Haddock BL,Hopp Marshak Hp,Mason JJ,et al.The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women[].Sports Medicine.2000
  • 4Pabor M,Elam MB,Garrison RJ,et al.Emerging noninvasive biochemical measure to predict cardiovascular risk[].Archives of Internal Medicine.1999
  • 5Salomaa V,Stinson V,Kark JD,et al.Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study-Atherosclerosis Risk in Communities Study[].Circulation.1995
  • 6Salomaa V,Stinson V,Kark JD,et al.Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study-Atherosclerosis Risk in Communities Study[].Circulation.1995
  • 7Hwang S,Ballantyne CM,Sharrett AR,et al.Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk in Communities (ARIC) study[].Circulation.1997

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部